Cintas Corp Director Joseph Scaminace Receives Annual Equity Award
CINTAS CORP
Subscribe to track CTAS
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
# Insider Transaction Report: CINTAS CORP (CTAS)
- **Insider:** Joseph Scaminace (Director)
- **Transaction Date:** 2026-10-28
- **Transaction Type:** Grant / Award (Code A)
- **Shares Granted:** 459 restricted shares @ $0.00
- **Derivative Grant:** 1,648 Stock Options @ $212.81 exercise price
- **Post-Transaction Holdings:** 44,055 common shares directly owned
- **Significance:** Low (Routine Annual Director Equity Compensation)
Comprehensive Analysis
Executive Summary
On October 28, 2026, Cintas Corporation (NASDAQ: CTAS) Director Joseph Scaminace was granted equity awards consisting of 459 restricted shares of common stock and 1,648 non-qualified stock options. The filing was reported on Form 4 on October 29, 2026.
Transaction Breakdown
-
Restricted Common Stock Grant:
- Shares: 459 shares
- Grant Price: $0.00
- Vesting Terms: Cliff vests on the first anniversary of the grant date (October 28, 2027) pursuant to the 2016 Amended and Restated Equity and Incentive Compensation Plan.
- Post-Transaction Ownership: 44,055 direct common shares.
-
Stock Option Grant (Derivative):
- Underlying Shares: 1,648 common shares
- Exercise Price: $212.81 per share
- Expiration Date: October 28, 2036 (10-year term)
- Vesting Terms: Cliff vests on the first anniversary of the grant date.
Market & Strategic Context
These transactions represent standard, non-discretionary annual compensation awarded to non-employee directors under the company's equity incentive plan. Because no open-market purchase or sale occurred and no cash consideration was exchanged, this filing has low predictive significance for CTAS stock price performance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.